...
机译:通过PIDA介导的分子内氧化环化的3-氨基-5-芳基-1,2,4-二氧化氮的体积合成
Shenyang Pharmaceut Univ Key Lab Struct Based Drug Design &
Discovery Minist Educ 103 Wenhua Rd Shenyang 110016 Peoples R China;
Shenyang Pharmaceut Univ Key Lab Struct Based Drug Design &
Discovery Minist Educ 103 Wenhua Rd Shenyang 110016 Peoples R China;
Shenyang Pharmaceut Univ Key Lab Struct Based Drug Design &
Discovery Minist Educ 103 Wenhua Rd Shenyang 110016 Peoples R China;
Shenyang Pharmaceut Univ Key Lab Struct Based Drug Design &
Discovery Minist Educ 103 Wenhua Rd Shenyang 110016 Peoples R China;
Shenyang Pharmaceut Univ Key Lab Struct Based Drug Design &
Discovery Minist Educ 103 Wenhua Rd Shenyang 110016 Peoples R China;
Shenyang Pharmaceut Univ Key Lab Struct Based Drug Design &
Discovery Minist Educ 103 Wenhua Rd Shenyang 110016 Peoples R China;
Shenyang Pharmaceut Univ Key Lab Struct Based Drug Design &
Discovery Minist Educ 103 Wenhua Rd Shenyang 110016 Peoples R China;
机译:通过PIDA介导的分子内氧化环化的3-氨基-5-芳基-1,2,4-二氧化氮的体积合成
机译:PIDA介导的分子内氧化C-N键形成,用于直接合成氨基尼喹啉
机译:PIDA介导的分子内氧化C-N键形成,用于直接合成氨基尼喹啉
机译:通过Pd(II) - 催化分子内氧化胺化(摘要)对环己烷稠合的六和八元杂环的合成
机译:通过砜,亚砜和膦酸酯的碳负离子与氨基甲酸酯和酰胺的分子内环化反应合成氮杂环化合物。
机译:通过串联酰胺化/分子内氮杂-Wittig反应轻松合成RSV抑制剂的前体121-噻二嗪
机译:与腈氧化物的互变异构依赖性内酰胺环加成:1,2,4-恶二唑[4,5-a]吲哚酮衍生物的简便合成